International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 31-37 , 1 May 2010

Quality of Life After Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer

  • Noëlle C. van der Voort van Zyp, M.D.

      Affiliations

    • Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • Corresponding Author InformationReprint requests to: N. C. van der Voort van Zyp, M.D., Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301 3075 EA Rotterdam, The Netherlands. Tel: (+31) 1 7041111; Fax: (+31) 1 7041013
    • ,
  • Jean-Briac Prévost, M.D.

      Affiliations

    • Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Bronno van der Holt, Ph.D.

      Affiliations

    • Department of Trials and Statistics, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Cora Braat, M.A.N.P.

      Affiliations

    • Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Robertus J. van Klaveren, M.D., Ph.D.

      Affiliations

    • Department of Pulmonology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Peter M. Pattynama, Prof. M.D.

      Affiliations

    • Department of Radiology, Erasmus MC, Rotterdam, The Netherlands
    • ,
  • Peter C. Levendag, Prof. M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Joost J. Nuyttens, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

Received 30 January 2009 ,Revised 17 April 2009 ,Accepted 24 April 2009.

References 

  1. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
  2. Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer. 2004;45:45–55
  3. Ng AW, Tung SY, Wong VY. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer–-Report on clinical outcome and dose to critical organs. Radiother Oncol. 2008;87:24–28
  4. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–1631
  5. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373–383
  6. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–626
  7. Nuyttens JJ, Prevost JB, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol. 2006;45:961–965
  8. Prevost JB, Nuyttens JJ, Hoogeman MS, et al. Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: Preliminary results. Eur Radiol. 2008;
  9. Sayeh SWJ, Main WT, et al. Respiratory motion tracking for robotic radiosurgery. New York: Springer-Verlag; 2007;
  10. Hoogeman M, Joost Nuyttens J-BP, Pöll J, Levendag P, Heijmen B. Clinical accuracy of the respiratory tumor tracking system of the CyberKnife: Assessment by analysis of log files. Int J Radiat Oncol Biol Phys. In press.
  11. Seppenwoolde Y, Berbeco RI, Nishioka S, et al. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: A simulation study. Med Phys. 2007;34:2774–2784
  12. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–692
  13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  14. Program CTE: Common terminology criteria for adverse events V. August 9, 2006. Available at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed August 18, 2009.
  15. Langendijk JA, Aaronson NK, de Jong JM, et al. Quality of life after curative radiotherapy in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;53:847–853
  16. Collins BT, Erickson K, Reichner CA, et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol. 2007;2:39
  17. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  18. Mendez Romero A, Wunderink W, van Os RM, et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys. 2008;70:1447–1452
  19. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol. 2000;18:106–115
  20. Win T, Sharples L, Wells FC, et al. Effect of lung cancer surgery on quality of life. Thorax. 2005;60:234–238
  21. Zieren HU, Muller JM, Hamberger U, et al. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardiothorac Surg. 1996;10:233–237
  22. Schulte T, Schniewind B, Dohrmann P, et al. The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non small cell lung cancer. Chest. 2009;74:297–303
  23. Balduyck B, Hendriks J, Lauwers P, et al. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer. 2007;56:423–431
  24. Kenny PM, King MT, Viney RC, et al. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer. J Clin Oncol. 2008;26:233–241
  25. Handy JR, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 2002;122:21–30
  26. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5:555–567
  27. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–144

 Conflict of interest: none.

PII: S0360-3016(09)00726-3

doi: 10.1016/j.ijrobp.2009.04.080

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 31-37 , 1 May 2010

Article Tools

* Image Usage & Resolution